Ortiz VA, Cortés PEC

Language: Spanish
References: 19
Page: 46-49
PDF size: 120.02 Kb.

ABSTRACT

Niacinamide, the amide form of vitamin b3, precursor of numerous metabolic reactions, especially the production of atp, is a component widely used in cosmetic dermatology, due to its versatility and safety profile in skin care. Some of its effects are a decrease in inflammation and pigmentation, sun protection and improvement in the skin’s protective barrier. Here we will review the evidence supporting the use of niacinamide for various dermatological indications, including acne, atopic dermatitis, rosacea, melasma, photoaging and photocarcinogenesis.

REFERENCES

1. Bissett DL, Oblong JE y Berge CA, Niacinamide: a b vitaminthat improves aging facial skin appearance, American Societyfor Dermatology Surgery 2005; 31(7):860-5. doi: 10.1111/j.1524-4725.2005.31732.

2. Rolfe HM, A review of nicotinamide: treatment of skin diseasesand potential side effects, Journal of Cosmetic Dermatology2014; 13(4):324-8. doi: 10.1111/jocd.12119.

3. Wohlrab J y Kreft D, Niacinamide mechanism of action and itstopical use in dermatology, Skin Pharmacology and Physiology2014; 27(6):311-5. doi: 10.1159/000359974.

4. Iliopoulos F et al., Topical delivery of niacinamide: influence ofneat solvents, Int J Pharm 2020; 15(579):119137. doi: 10.1016/j.ijpharm.2020.119137.

5. Zhang Y, Lane ME y Moore DJ, An investigation of the influenceof peg 400 and peg6-caprylic/capric glycerides on dermaldelivery of niacinamide, Polymers Basel 2020; 12(12):2907. doi:10.3390/polym12122907.

6. Chen AC y Damian DL, Nicotinamide and the skin, AustralasianJournal of Dermatology 2014; 55(3):169-75. doi: 10.1111/ajd.12163.

7. Kaymak Y y Önder M, An investigation of efficacy of topical niacinamidefor the treatment of mild and moderate acne vulgaris,J Turk Acad Dermatol 2008; 2(4).

8. Villani A et al., Efficacy and safety of a new topical gel formulationcontaining retinol encapsulated in glycospheres and hydroxypinacoloneretinoate, an antimicrobial peptide, salicylicacid, glycolic acid and niacinamide for the treatment of mildacne: preliminary results of a 2-month prospective study, G ItalDermatol Venereol 2020; 155(5):676-9. doi: 10.23736/S0392-0488.20.06581-5.

9. Matts PJ, Oblong J y Bissett D, Niacinamide up-regulates epidermalceramides synthesis with concurrent epidermal barrierbenefits, ifscc Magazine 2002; (5):285-9.

10. Wozniacka A, Wozniacka W y Sysa-Je, Topical application ofnadh for the treatment of rosacea and contact dermatitis,Clinical and Experimental Dermatology 2003; (28)61-3. doi:10.1046/j.1365-2230.2003.01118.x.

11. Berson DS et al., Niacinamide: a topical vitamin with widerangingskin appearance benefits, American Society for DermatologicSurgery 2014; 31(7 Pt 2):860-5. doi: 10.1111/j.1524-4725.2005.31732.

12. Navarrete S et al., A double-blind, randomized clinical trialof niacinamide 4% versus hydroquinone 4% in the treatmentof melasma, Dermatol Res Pract 2011; 379173. doi:10.1155/2011/379173.

13. Namazi MR, Review nicotinamide in dermatology: a capsulesummary, International Journal of Dermatology 2007;46(12):1229-31. doi: 10.1111/j.1365-4632.2007.03519.x.

14. Bissett DL, Miyamoto K, Sun P et al., Topical niacinamide reducesyellowing, wrinkling, red blotchiness, and hyperpigmentedspots in aging facial skin, Society of Cosmetic Scientists andthe Société Française de Cosmetologie 2004; 26(5):231-8. doi:10.1111/j.1467-2494.2004.00228.x.

15. Streilein W et al., Relationship between ultraviolet radiationinducedimmunosuppression and carcinogenesis, Societyfor Investigative Dermatology 1994; 103(5):107S-111. doi:10.1111/1523-1747.ep12399400.

16. Rovito HA y Oblong JE, Nicotinamide preferentially protects glycolysisin dermal fibroblasts under oxidative stress conditions,British Journal of Dermatology 2013; 169(2):15-24. doi: 10.1111/bjd.12365.

17. Damian DL, Photoprotective effects of nicotinamide, Photochemicaland Photobiological Sciences 2010; 9(4):578-85. doi:10.1039/b9pp00146h.

18. Surjana D, Halliday GM, Martin AJ et al., Oral nicotinamide reducesactinic keratoses in phase ii double-blinded randomizedcontrolled trials, Journal of Investigative Dermatology 2012;132(5):1497-500.

19. Chen AC et al., A phase 3 randomized trial of nicotinamide forskin-cancer chemoprevention, New England Journal of Medicine 2015; 373:1618-26. doi: 10.1056/NEJMoa1506197.